Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 19, 2023 - Issue 3
Submit an article Journal homepage
607
Views
1
CrossRef citations to date
0
Altmetric
Immunotherapy - Cancer

Long-lasting complete response to SHR-1701 plus famitinib in refractory advanced gallbladder cancer: A case report

Lixia Yia Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, China;c Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaView further author information
,
Xiaoyan Zhua Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, China;c Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaView further author information
,
Jing Xiea Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, China;c Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaCorrespondence[email protected]
View further author information
&
Zhiqiang Menga Department of Integrative Oncology, Fudan University Shanghai Cancer Center, Shanghai, China;b Department of Minimally Invasive Therapy Center, Fudan University Shanghai Cancer Center, Shanghai, China;c Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, ChinaView further author information
Article: 2294575 | Received 14 Aug 2023, Accepted 11 Dec 2023, Published online: 21 Dec 2023

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.